The Science Behind Creatine
Dr. Robert Marshall, Team Physician at RB Leipzig: The Science Behind Creatine
Dr. Robert Percy Marshall is a proven expert in the medical aspects of competitive sports: a specialist in physical and rehabilitative medicine as well as Master of Medical Administration in micronutrient therapy and regulatory medicine, he has headed the medical department of Bundesliga soccer club RB Leipzig since 2018. His treatment spectrum includes Traditional Chinese Medicine as well as othomolecular and osteopathic approaches in addition to conservative orthopedic and functional sports medicine. Previously, he was responsible for the sports medicine care of the HSV youth academy from 2012. He is also co-founder of the Institute for Sports and Exercise Medicine at the University Medical Center Hamburg-Eppendorf.
Marshall knows the positive effects of creatine: he recently published the video "Creatine in Athletes'Performance" on Youtube, in which he explains in detail the role of creatine in sports and its mode of action in the body as well as additional potential of the micronutrient, and together with three colleagues the review paper "Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review" in the magazine Nutrients.
"Every day, 'mitochondrial dysfunction' is coming more and more into the focus of science and medicine, for example, Dr. Stephan Barth, Dr. Jens Freese and Alexis Diaz-Vegas," Marshall points out, continuing, "Poor function of our cellular power plants is associated with a variety of so-called diseases of civilization. Long Covid Syndrome - or Post Viral Fatigue Syndrome - also appears to originate in this dysfunction. While creatine was once a dietary supplement used only by athletes, we now know that it can also be therapeutic and preventive for a variety of diseases."
A brief summary of some important points of the video from Dr. Robert Marshall:
-
Creatine is the most studied dietary supplement in professional sports, primarily because of its strength-enhancing properties
-
The benefits of creatine go beyond its positive influence on athletic performance: studies show a direct effect on mitochondrial dysfunction
-
Creatine can prevent cell damage due to circulatory disorders, mild traumatic brain injury (concussion), and sudden cardiac death.
-
Recent research suggests a positive effect on cognitive abilities, depression and chronic fatigue.
The paper "Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review" in full here.
Contact
Dr. Jürgen Bezler
About Alzchem
Alzchem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. Alzchem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, Alzchem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.